Entrepreneur Duke Rohlen creates California-based Ajax Health under a new model. Partnering with private equity firms, Rohlen considers a $1 billion bid to buy medical device maker Cordis. If Ajax’s bid is successful, they will invest an additional $300 million to fund an accelerator to develop innovative new products to drive growth. Is Cordis the right opportunity for Rohlen and his team? Ajax Health founder Duke Rohlen (HBS MBA 2001) and HBS Professor Regina Herzlinger join host Brian Kenny to discuss the key success factors for both start-up and established medical technology firms. The case “Ajax Health: A New Model for Medical Technology Innovation” showcases how to structure a firm—in any industry—to maximize innovation and financial returns by better aligning incentives for the different skill sets required.

Ver todos los episodios